Sorrento Therapeutics
North America, California, United States, San Diego
Description
Sorrento Therapeutics is focused on the development of proprietary drug therapeutics for addressing unmet medical needs.
Investor Profile
Sorrento Therapeutics has made 5 investments, with 0 in the past 12 months and 40% as lead.
Stage Focus
- Series Unknown (20%)
- Series B (20%)
- Post Ipo Equity (20%)
- Seed (20%)
- Private Equity (20%)
Country Focus
- United States (100%)
Industry Focus
- Health Care
- Biotechnology
- Therapeutics
- Wellness
- Health Diagnostics
- Life Science
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
'%3e%3cg id='b'%3e%3cpath id='a' stroke='%23000' stroke-width='2' d='M-6-25H6m-12 3H6m-12 3H6'/%3e%3cuse xlink:href='%23a' y='44'/%3e%3c/g%3e%3cpath stroke='%23fff' d='M0 17v10'/%3e%3ccircle r='12' fill='%23cd2e3a'/%3e%3cpath fill='%230047a0' d='M0-12A6 6 0 0 0 0 0a6 6 0 0 1 0 12 12 12 0 0 1 0-24z'/%3e%3c/g%3e%3cg transform='rotate(-123.69)'%3e%3cuse xlink:href='%23b'/%3e%3cpath stroke='%23fff' d='M0-23.5v3M0 17v3.5m0 3v3'/%3e%3c/g%3e%3c/svg%3e)
